BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 25620624)

  • 21. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
    Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
    Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of liver fat in the presence of iron overload.
    Horng DE; Hernando D; Reeder SB
    J Magn Reson Imaging; 2017 Feb; 45(2):428-439. PubMed ID: 27405703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
    Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimation.
    Levin YS; Yokoo T; Wolfson T; Gamst AC; Collins J; Achmad EA; Hamilton G; Middleton MS; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2014 Mar; 39(3):567-75. PubMed ID: 23720420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.
    Yu NY; Wolfson T; Middleton MS; Hamilton G; Gamst A; Angeles JE; Schwimmer JB; Sirlin CB
    Clin Radiol; 2017 May; 72(5):425.e9-425.e14. PubMed ID: 28063601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
    Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
    World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Density Fat Fraction Measurements at 1.5- and 3-T Hepatic MR Imaging: Same-Day Agreement among Readers and across Two Imager Manufacturers.
    Serai SD; Dillman JR; Trout AT
    Radiology; 2017 Jul; 284(1):244-254. PubMed ID: 28212052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise.
    Hong CW; Hamilton G; Hooker C; Park CC; Tran CA; Henderson WC; Hooker JC; Fazeli Dehkordy S; Schwimmer JB; Reeder SB; Sirlin CB
    Abdom Radiol (NY); 2019 Oct; 44(10):3295-3303. PubMed ID: 31172210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects.
    Negrete LM; Middleton MS; Clark L; Wolfson T; Gamst AC; Lam J; Changchien C; Deyoung-Dominguez IM; Hamilton G; Loomba R; Schwimmer J; Sirlin CB
    J Magn Reson Imaging; 2014 May; 39(5):1265-71. PubMed ID: 24136736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D Chemical Shift-Encoded MRI for Volume and Composition Quantification of Abdominal Adipose Tissue During an Overfeeding Protocol in Healthy Volunteers.
    Nemeth A; Segrestin B; Leporq B; Seyssel K; Faraz K; Sauvinet V; Disse E; Valette PJ; Laville M; Ratiney H; Beuf O
    J Magn Reson Imaging; 2019 Jun; 49(6):1587-1599. PubMed ID: 30328237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
    Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
    Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point-of-care magnetic resonance technology to measure liver fat: Phantom and first-in-human pilot study.
    Barahman M; Grunvald E; Prado PJ; Bussandri A; Henderson WC; Wolfson T; Fowler KJ; Sirlin CB
    Magn Reson Med; 2022 Oct; 88(4):1794-1805. PubMed ID: 35611691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
    Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High SNR Acquisitions Improve the Repeatability of Liver Fat Quantification Using Confounder-corrected Chemical Shift-encoded MR Imaging.
    Motosugi U; Hernando D; Wiens C; Bannas P; Reeder SB
    Magn Reson Med Sci; 2017 Oct; 16(4):332-339. PubMed ID: 28190853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.